Isofit 10mg Tablet contains dydrogesterone, a synthetic progestogen structurally similar to natural progesterone, used primarily in the management of various gynecological conditions. It is indicated for the treatment of menstrual disorders such as irregular menstruation, secondary amenorrhea, and dysfunctional uterine bleeding. Additionally, Isofit is employed in hormone replacement therapy to counteract progesterone deficiency and in the prevention of threatened miscarriage in early pregnancy. The pharmacological action of dydrogesterone involves binding to progesterone receptors, thereby regulating the endometrial lining and supporting its secretory transformation, which is essential for maintaining pregnancy and normal menstrual cycles. Isofit 10mg is administered orally, with dosage and duration tailored according to the specific clinical indication and patient response. The drug is generally well-tolerated, with adverse effects being infrequent and mild, including nausea, headache, and breast tenderness. Contraindications include known hypersensitivity to dydrogesterone or any tablet excipients, active thromboembolic disorders, and hormone-dependent malignancies. Isofit should be used cautiously in patients with liver dysfunction or a history of thromboembolic events. Regular monitoring by a healthcare professional is advised to ensure therapeutic efficacy and safety during treatment.